DrugPatentWatch Database Preview
Email this page to a colleagueSee Plans and Pricing
« Back to Dashboard
Atrasentan is an investigational drug.
There have been 17 clinical trials for Atrasentan. The most recent clinical trial was a Phase 3 trial, which was initiated on June 1st 2001.
The most common disease conditions in clinical trials are Prostatic Neoplasms, Kidney Diseases, and Diabetic Nephropathies. The leading clinical trial sponsors are Abbott, AbbVie (prior sponsor, Abbott), and National Cancer Institute (NCI).
Recent Clinical Trials for Atrasentan
|Atrasentan Spermatogenesis and Testicular Function||AbbVie||Phase 2|
|Study Of Diabetic Nephropathy With Atrasentan||AbbVie||Phase 3|
|A Prospective, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate Efficacy and Safety of Atrasentan, Including Thoracic Bioimpedance, in Type 2 Diabetic Subjects With Nephropathy||AbbVie (prior sponsor, Abbott)||Phase 2|